Who
Kate McKinley
Chief Business Officer
Company insider
Files Form 4 as: Chief Business Officer, Rani Therapeutics Holdings.
In numbers
- Trades disclosed
- 9
- Buys
- 1
- Sells
- 0
- Bought
- $30K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 May 2023
- Last trade
- 3 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Dec 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 5 Jun 2026 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —805,500 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —805,500 at $0.00 | filing |
| 1 Aug 2025filed 5 Aug 2025 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 23 May 2025filed 23 May 2025 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —325,000 at $0.00 | filing |
| 13 Dec 2024filed 16 Dec 2024 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Bought | $30K17,960 at $1.67 | filing |
| 21 Mar 2024filed 22 Mar 2024 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —323,500 at $0.00 | filing |
| 16 Dec 2023filed 19 Dec 2023 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code D | —250,000 | filing |
| 16 Dec 2023filed 19 Dec 2023 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 | filing |
| 22 May 2023filed 8 Aug 2023 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.